Skip to content

Clinical trials

Completed Phase 1 Cognition Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognition Disorders Phase: Phase 1 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20103
20112
20161
20171
20202
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AlzeCure Pharma3
Janssen Pharmaceutica N.V., Belgium2
Siena Biotech S.p.A.2
NXTech1
National Institute of Mental Health (NIMH)1
University of California, San Diego1
University of Maryland, Baltimore1
University of Rochester1
University of Southern California1
VA Office of Research and Development1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognition Disorders15
Alzheimer Disease3
Cognitive Dysfunction3
Mental Disorders3
Schizophrenia3
Acquired Immunodeficiency Syndrome2
Basal Ganglia Diseases2
Brain Diseases2
Central Nervous System Diseases2
Chorea2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.